Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Invex Therapeutics Ltd. ( (AU:IXC) ) has shared an update.
Invex Therapeutics Ltd has been suspended from quotation on the ASX due to non-compliance with the Corporations Act 2001, specifically for not having sufficient directors. The suspension will remain until the company meets the ASX’s listing rules, impacting its market operations and requiring resolution to regain trading status.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd is a company listed on the Australian Securities Exchange (ASX) and operates in the biotechnology sector. The company focuses on developing therapeutic solutions, although specific products or market focus are not detailed in the provided text.
Average Trading Volume: 67,028
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$8.64M
Find detailed analytics on IXC stock on TipRanks’ Stock Analysis page.